Search Ontology:
ChEBI
alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-alpha-D-GalpNAc
- Term ID
- CHEBI:71602
- Synonyms
-
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->6)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-alpha-D-glucopyranose
- alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-Neu5Ac-(2->6)]-alpha-D-GalNAc
- alpha-Neu5Ac-(2->6)-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)]-alpha-D-GalNAc
- alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)[alpha-Neup5Ac-(2->6)]-alpha-D-GalpNAc
- N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-alpha-D-glucosamine
- N-acetyl-alpha-neuraminyl-(2->6)-[N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)]-N-acetyl-alpha-D-glucosamine
- Neu5Aca2-6(Neu5Aca2-3Galb1-3)GalNAca
- Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAcalpha
- O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->6)-O-[O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)]-2-(acetylamino)-2-deoxy-alpha-D-galactopyranose
- WURCS=2.0/3,4,3/[a2112h-1a_1-5_2*NCC/3=O][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3-3/a3-b1_a6-d2_b3-c2
- Definition
- alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-alpha-D-GalpNAc in which the anomeric configuration of the reducing-end N-acetyl-D-glucosamine residue is alpha.
- References
-
- GlyGen:G01614ZM
- GlyTouCan:G01614ZM
- PMID:19443021
- PMID:25568069
- PMID:31537530
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-alpha-D-GalpNAc
Phenotype where environments contain alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-alpha-D-GalpNAc
Phenotype modified by environments containing alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-alpha-D-GalpNAc
Human Disease Model